Browse/search for people

Professor Imre Berger


Imre Berger was trained as a biochemist and synthetic biologist at Leibniz University and Medical School (MHH) in Hannover (Germany), at MIT (Cambridge, USA), and at ETH Zurich (Switzerland). Imre's team develops enabling methods for DNA delivery and genome engineering, engineers synthetic vaccines and nanosensors and researches the structure and mechanism of multiprotein complexes in human health and disease.

After Group Leader posts at ETH (2005) and EMBL (2007), Berger joined Bristol as Full Professor of Biochemistry (2014) with a joint appointment in Chemistry (2019). He is Founding Director of the Max Planck Centre for Minimal Biology in Bristol, Director of the BBSRC/EPSRC research centre for synthetic biology BrisSynBio and Co-director of the Bristol Biodesign Institute BBI. 

Imre Berger holds international patents for DNA and protein technologies, co-founded three biotech companies and received numerous distinctions, notably the Swiss Technology Award, the W.A. DeVigier Foundation Award and a Wellcome Trust Senior Investigator Award for his innovative research. Since 2019, he is Investigator of the European Research Council (ERC).

Prof. Berger has participated in leading roles in numerous European Commission (EC) projects, including the pan-European structural biology infrastructure INSTRUCT. He has been Coordinator of the EC FP7 HEALTH ComplexINC project enhancing production tools for complex biologics in academic and industrial R&D  (2011-2016) and is partner in the EPSRC funded Innovative Future Vaccine Manufacturing Research Hub. 



School of Biochemistry

Other sites

School of Biochemistry staff